SJP Project Solutions Completes Built-Out of Helsinn’s 25,000-SF Workspace at 200 Wood Avenue South in Iselin, N.J.
Global biopharmaceutical company relocates to the newly repositioned Metropark campus known for its infrastructure, modern amenities and ample outdoor space
![SJP Project Solutions Completes Built-Out of Helsinn’s 25,000-SF Workspace at 200 Wood Avenue South in Iselin, N.J.](https://sjpproperties.com/wp-content/uploads/2024/04/KM_230324B_0003.jpg)
April 19, 2023 | Press Release
Iselin, N.J. — SJP Project Solutions — SJP Properties’ third-party development management arm — has successfully completed the transformative build-out of pharmaceutical company Helsinn’s specialized workspace at SJP Properties’ 200 Wood Avenue South in Iselin, New Jersey. The global biopharmaceutical company now occupies 25,000 square feet at the office campus and joins Siemens, a multinational technology company; a national insurance carrier, international transport company DSV and the globally ranked financial services company Credit Agricole, all of which have established offices at 200 Wood Avenue South since SJP acquired the building in early 2020.
Helsinn, a fully-integrated global biopharmaceutical company focused on oncology and rare diseases, relocated from 170 Wood Avenue South, and was drawn to the property’s accessibility to skilled labor across the state of New Jersey, as well as its on-site amenities and ample green space. The company selected SJP Project Solutions to execute a full build-out of the company’s first-floor office, which included conference and meeting facilities, a training room, open collaboration areas, a wellness room and a private outdoor terrace. Helsinn was represented in the lease transaction by Jim Postell at Colliers International. Wes Moore of CBRE represented SJP.
“In spite of economic headwinds faced by many industries, New Jersey’s life sciences sector continues to evolve and thrive at an incredible rate,” says Alexander Erdos, Senior Vice President – Leasing & Marketing at SJP Properties. “Not only is SJP able to offer these companies resilient workplace environments, but we are able to deliver built-to-suit spaces tailored to address unique tenant needs. The future growth of the state’s life sciences sector is dependent upon the ability of these companies to tap into the highly educated labor pool within surrounding markets. SJP’s presence in New Jersey continues to facilitate this connection and compel more top-tier companies to establish footprints in transit-oriented suburbs like Iselin.”
Optimally positioned near public transit in Iselin’s Metropark submarket, the 200 Wood Avenue South campus offers modern, purpose-built workspaces and an array of on-site lifestyle amenities. Upon acquisition of the property, SJP executed a comprehensive strategy to reposition it, paying homage to its postmodernist architecture with a complete interior and exterior renovation. It also outfitted the property with new building systems and indoor/outdoor lifestyle amenities — a brand new lobby, state-of-the-art fitness center, collaborative common areas, including landscaped outdoor meeting areas; nationally recognized food operators within the on-site dining area and ample on-site parking. SJP is also providing its signature hospitality and concierge services as part of its property management offering. Additionally, some of the building’s new systems include air filtration upgrades for improved air quality to create a healthier environment for employees.
Spanning 270,000 square feet, 200 Wood Avenue South has the ability to attract New Jersey’s top talent where the labor markets converge and is optimally positioned within walking distance to the Metropark Train Station, which offers NJ TRANSIT and Amtrak Acela services. 200 Wood Avenue South is also conveniently located near the cross-sections of Lincoln Highway, Middlesex Turnpike and the Garden State Parkway.
For more information about 200 Wood Avenue South, please visit www.woodavemetropark.com.
About SJP Properties
Headquartered in New York City, SJP Properties is a vertically integrated commercial, residential, and industrial real estate owner, developer, investor, asset manager, construction manager and property manager. The expertise of the company’s core in-house team of professionals encompasses the entire development process, from site selection through coordination of tenant move-in for large multi-phase projects, including numerous Class A build-to-suit developments and individual tenant build-outs. Well known for the creation of unparalleled lifestyle-focused developments, SJP is committed to meticulous design and engineering development plans that reflect a keen understanding of market demand. Following successful industrial build-outs in the Tri-state area, SJP is expanding its warehousing portfolio across the Eastern Seaboard, most recently with an approximately seven-million-square-foot industrial development strategically located near the Port of Savannah.
Having sustained an unblemished track record of success, SJP has established relationships with many of the industry’s leading investors and financial institutions, providing unparalleled access to capital. For more information, call 212-335-2200 or visit www.sjpproperties.com.
About Helsinn Therapeutics
Helsinn is a fully integrated global biopharma company headquartered in Lugano, Switzerland. It is focused on improving the lives of cancer patients all over the world with a leading position in cancer supportive care and a focus on cancer therapeutics and rare diseases.
Helsinn is a third-generation family-owned company, that, since 1976 has been focused on improving the lives of patients, guided by core values of respect, integrity and quality. Helsinn’s unique business model enables it to in-license or acquire assets at a late stage of development.
It has a commercial presence in 190 countries either directly, with operating subsidiaries in the U.S. and China, or via its network of long-standing trusted partners. Helsinn also has a fully integrated supply chain and product development through its subsidiary in Ireland, Helsinn Birex Pharmaceuticals Ltd.
Helsinn plays an active and central role in promoting social transformation in favor of people and the environment. Sustainability is at the heart of everything we do, which is reinforced in the company’s strategic plan by a commitment to sustainable growth.
To learn more about Helsinn please visit: www.helsinn.com.